The effect of drugs interfering with biogenic amine metabolism on basal gastric secretion in the rat.
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004221:Disulfiram / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D005750:Gastric Juice / Q000201:enzymology / Q000378:metabolism*; D005753:Gastric Mucosa / Q000187:drug effects*; D007099:Imipramine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010434:Pepsin A / Q000378:metabolism; D051381:Rats; D012636:Secretory Rate / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism*; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D002395:Catecholamines; D008781:Methyltyrosines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D014446:Tyrosine 3-Monooxygenase; D010434:Pepsin A; D007545:Isoproterenol; D007099:Imipramine; D010134:Fenclonine; D009526:Nialamide; D004221:Disulfiram; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine